Skip to content

PressReach

SEARCH icon
  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos
Search

SEARCH FOR AN ARTICLE

  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos

PressReach

icon

      HomeNASDAQ:VRTX

      NASDAQ:VRTX

      Vertex Stock: the Next Blockbuster Drug Stock to Invest In?
      Investing News

      Vertex Stock: the Next Blockbuster Drug Stock to Invest In?

      February 23, 2024
      Vertex Surpasses Industry Performance Year to Date: Unveiling the Factors
      Investing News

      Vertex Surpasses Industry Performance Year to Date: Unveiling the Factors

      August 30, 2023
      Vertex Reports Robust Growth Fueled by Trikafta/Kaftrio; Fair Value Estimate Raised 3%
      Investing News

      Vertex Reports Robust Growth Fueled by Trikafta/Kaftrio; Fair Value Estimate Raised 3%

      August 7, 2023
      FDA Approves Vertex’s CF Drug for Toddlers
      Investing News

      FDA Approves Vertex’s CF Drug for Toddlers

      September 5, 2022

       

      LATEST NEWS

      • Investing News Beta Technologies Q3 IPO Insights
      • Investing News Salesforce Reports Robust Q3 2026 Earnings
      • Investing News Salesforce’s Stock Boost Amid Raised Guidance
      • Investing News Macy’s Q3 2025 Earnings Overview
      • Investing News Okta’s Strong Q3 2026 Earnings Boost Shares

      PressReach

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from PressReach.

      I want e-mail alerts, updates, and offers and agree to the PressReach privacy policy.

      Market Jar Media Inc. © 2025